Pillstats
Rx only · Injection, Solution · Intravenous

Heparin Sodium

Heparin Sodium

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US82 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCB01AB01
RxCUI (US)5224
US makers15 labelers
Packages93
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.19$4.38$6.57$8.77Jul 2025Mar 2026Jul 2026
$2.706
Latest avg · Jul 22, 2026
-64%
Since Jul 23, 2025
15
Active US suppliers
37%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

27K55K82K110K2025 Q12025 Q22025 Q32025 Q42026 Q1
68K
Rx · 2026 Q1
3.6M
Units dispensed
-28%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it15 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown20SUPPLYING
Hospira, Inc.unknown14SUPPLYING
Sagent Pharmaceuticalsunknown12SUPPLYING
Hepalink USA Inc.unknown9SUPPLYING
Sandoz Incunknown9SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown7SUPPLYING
Cardinal Health 107, LLCunknown6SUPPLYING
Baxter Healthcare Corporationunknown4SUPPLYING
NorthStar Rx LLCunknown3SUPPLYING
Henry Schein Inc.unknown2SUPPLYING
Meitheal Pharmaceuticals Inc.unknown2SUPPLYING
BE Pharmaceuticals Inc.unknown2SUPPLYING
Medical Purchasing Solutions, LLCunknown2SUPPLYING
Phlow Corporationunknown1SUPPLYING
McKesson Corporation dba SKY Packagingunknown0SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 1, 2024
    RECALLRecall (Class I): Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Sing…

    Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. — Recalling firm: Baxter Healthcare Corporation — Nationwide in the USA

  • Dec 29, 2022
    RECALLRecall (Class II): Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Cas…

    Lack of assurance of sterility: Bags have the potential to leak. — Recalling firm: Pfizer Inc. — Nationwide in the USA.

  • Nov 14, 2017
    SHORTAGEDrug shortage: Heparin Sodium Injection (Fresenius Kabi USA, LLC)

    Heparin Sodium Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.

  • Nov 14, 2017
    SHORTAGEDrug shortage: Heparin Sodium Injection (Baxter Healthcare)

    Heparin Sodium Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Hematology.

  • Jun 3, 2015
    RECALLRecall (Class II): Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only,…

    Subpotent Drug; out of specification results for heparin raw material — Recalling firm: Baxter Healthcare Corp — Nationwide

  • Oct 30, 2014
    RECALLRecall (Class II): Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, …

    Subpotent Drug: Heparin raw material was found to have low potency — Recalling firm: Baxter Healthcare Corp. — Nationwide

  • Sep 11, 2014
    RECALLRecall (Class I): HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL flexi…

    Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container. — Recalling firm: Hospira Inc. — Nationwide

  • Jun 6, 2014
    RECALLRecall (Class II): Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, S…

    Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag. — Recalling firm: Hospira Inc. — Nationwide

  • Jan 22, 2014
    RECALLRecall (Class II): Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx…

    Subpotent; 18 month time point — Recalling firm: Fresenius Kabi USA, LLC — Nationwide

  • Jan 9, 2014
    RECALLRecall (Class II): Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, Rx only. …

    Lack of Assurance of Sterility; potential leakage from administrative port. — Recalling firm: Hospira Inc. — Nationwide including Puerto Rico

  • May 21, 2013
    RECALLRecall (Class II): Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP Units, Viaflex Plus Container, 1000…

    Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. — Recalling firm: Baxter Healthcare Corp. — Nationwide & Puerto Rico